US00688A2050 - Common Stock
GLEN ALLEN, Va., April 22, 2024 (GLOBE NEWSWIRE) -- Adial Pharmaceuticals, Inc. (NASDAQ: ADIL) (“Adial” or the “Company”), a clinical-stage...
We're starting off Thursday with a breakdown of all the biggest pre-market stock movers traders will want to keep an eye on this morning!
Adial Pharmaceuticals stock is up on Wednesday with heavy trading of ADIL shares alongside positive coverage of its AUD treatment.
Findings underscore the liver safety of AD04 as compared to placebo in the prior Phase 3 clinical trial...
Received Favorable Feedback from US and EU Regulatory Agencies Advancing Discussions with Potential Strategic Partners Received $4.3 Million in Gross...
We're starting off the trading week with a breakdown of all the biggest pre-market stock movers worth watching on Monday morning!
CHARLOTTESVILLE, Va., March 01, 2024 (GLOBE NEWSWIRE) -- Adial Pharmaceuticals, Inc. (NASDAQ: ADIL) (“Adial” or the “Company”), a clinical-stage...